| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |